Stanford scientists cure type 1 diabetes in mice without insulin or drugs

Scientists at Stanford University have successfully cured type 1 diabetes in mice without relying on insulin or immunosuppressive drugs. The breakthrough uses a dual transplantation technique that restores insulin production while retraining the immune system. Researchers believe this approach could eventually transform treatment for humans with autoimmune diseases.

The study, led by Dr. Seung K. Kim, combined blood stem cell transplants with insulin-producing pancreatic islet cells from mismatched donors. This method not only restored insulin levels but also stopped the immune system from attacking the body's own islet cells. As a result, the treated mice remained diabetes-free for six months without needing insulin injections or medication.

The technique builds on earlier research where diabetes was reversed in mice through similar transplants. Importantly, the approach already exists in clinical practice for other conditions, suggesting it could be adapted for human use. While no human trials have begun as of February 2026, the findings offer hope for future treatments.

Dr. Kim and the team believe the method could extend beyond diabetes to other autoimmune diseases, such as rheumatoid arthritis and lupus. The key breakthrough was preventing immune rejection while restoring normal insulin function—something previous treatments struggled to achieve.

The study marks a significant step forward in autoimmune disease research, though human applications remain in the preclinical stage. If successfully translated, the method could eliminate the need for lifelong insulin therapy and immunosuppressive drugs. For now, further testing is required before clinical trials can begin.